These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 30744452)

  • 21. Diastolic Hypotension May Attenuate Benefits from Intensive Systolic Targets: Secondary Analysis of a Randomized Controlled Trial.
    Lee TC; Cavalcanti RB; McDonald EG; Pilote L; Brophy JM
    Am J Med; 2018 Oct; 131(10):1228-1233.e1. PubMed ID: 29906425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and Implications of Atrial Fibrillation/Flutter in Hypertension: Insights From the SPRINT Trial.
    Parcha V; Patel N; Kalra R; Kim J; Gutiérrez OM; Arora G; Arora P
    Hypertension; 2020 Jun; 75(6):1483-1490. PubMed ID: 32362231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of blood pressure-lowering treatment by the levels of baseline Framingham risk score: A post hoc analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
    Zhang L; Sun X; Liao L; Zhang S; Zhou H; Zhong X; Zhuang X; Liao X
    J Clin Hypertens (Greenwich); 2019 Dec; 21(12):1813-1820. PubMed ID: 31670874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial.
    Upadhya B; Rocco M; Lewis CE; Oparil S; Lovato LC; Cushman WC; Bates JT; Bello NA; Aurigemma G; Fine LJ; Johnson KC; Rodriguez CJ; Raj DS; Rastogi A; Tamariz L; Wiggers A; Kitzman DW;
    Circ Heart Fail; 2017 Apr; 10(4):. PubMed ID: 28364091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood pressure variability predicts adverse events and cardiovascular outcomes in SPRINT.
    Mezue K; Goyal A; Pressman GS; Matthew R; Horrow JC; Rangaswami J
    J Clin Hypertens (Greenwich); 2018 Sep; 20(9):1247-1252. PubMed ID: 29984884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Systolic Blood Pressure Lowering on the Risk of Stroke.
    Shihab S; Boucher RE; Abraham N; Wei G; Beddhu S
    Hypertension; 2022 Apr; 79(4):785-793. PubMed ID: 35114798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systolic and diastolic blood pressure time in target range and cardiovascular outcomes in patients with hypertension and pre-frailty or frailty status.
    Zhu J; Yang K; Liu W
    J Clin Hypertens (Greenwich); 2024 May; 26(5):514-524. PubMed ID: 38552135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit: A Secondary Analysis of the SPRINT Randomized Clinical Trial.
    Ghazi L; Shen J; Ying J; Derington CG; Cohen JB; Marcum ZA; Herrick JS; King JB; Cheung AK; Williamson JD; Pajewski NM; Bryan N; Supiano M; Sonnen J; Weintraub WS; Greene TH; Bress AP
    JAMA Netw Open; 2023 May; 6(5):e2314443. PubMed ID: 37204788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Personalizing the Intensity of Blood Pressure Control: Modeling the Heterogeneity of Risks and Benefits From SPRINT (Systolic Blood Pressure Intervention Trial).
    Patel KK; Arnold SV; Chan PS; Tang Y; Pokharel Y; Jones PG; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28373269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Individualising intensive systolic blood pressure reduction in hypertension using computational trial phenomaps and machine learning: a post-hoc analysis of randomised clinical trials.
    Oikonomou EK; Spatz ES; Suchard MA; Khera R
    Lancet Digit Health; 2022 Nov; 4(11):e796-e805. PubMed ID: 36307193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).
    Bress AP; Kramer H; Khatib R; Beddhu S; Cheung AK; Hess R; Bansal VK; Cao G; Yee J; Moran AE; Durazo-Arvizu R; Muntner P; Cooper RS
    Circulation; 2017 Apr; 135(17):1617-1628. PubMed ID: 28193605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.
    Böhm M; Schumacher H; Teo KK; Lonn EM; Mahfoud F; Mann JFE; Mancia G; Redon J; Schmieder RE; Sliwa K; Weber MA; Williams B; Yusuf S
    Lancet; 2017 Jun; 389(10085):2226-2237. PubMed ID: 28390695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Orthostatic Hypotension, Cardiovascular Outcomes, and Adverse Events: Results From SPRINT.
    Juraschek SP; Taylor AA; Wright JT; Evans GW; Miller ER; Plante TB; Cushman WC; Gure TR; Haley WE; Moinuddin I; Nord J; Oparil S; Pedley C; Roumie CL; Whittle J; Wiggers A; Finucane C; Anne Kenny R; Appel LJ; Townsend RR;
    Hypertension; 2020 Mar; 75(3):660-667. PubMed ID: 31983312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Estimated Pulse Wave Velocity With Survival: A Secondary Analysis of SPRINT.
    Vlachopoulos C; Terentes-Printzios D; Laurent S; Nilsson PM; Protogerou AD; Aznaouridis K; Xaplanteris P; Koutagiar I; Tomiyama H; Yamashina A; Sfikakis PP; Tousoulis D
    JAMA Netw Open; 2019 Oct; 2(10):e1912831. PubMed ID: 31596491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span: Secondary Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
    Vaduganathan M; Claggett BL; Juraschek SP; Solomon SD
    JAMA Cardiol; 2020 May; 5(5):576-581. PubMed ID: 32101262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular Risk in Patients With Treated Isolated Diastolic Hypertension and Isolated Low Diastolic Blood Pressure.
    Chang WL; Chen YF; Lee YH; Shiu MN; Chang PY; Guo CY; Huang CJ; Chiang CE; Chen CH; Chuang SY; Cheng HM
    J Am Heart Assoc; 2024 Apr; 13(8):e032771. PubMed ID: 38606761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study.
    Drawz PE; Pajewski NM; Bates JT; Bello NA; Cushman WC; Dwyer JP; Fine LJ; Goff DC; Haley WE; Krousel-Wood M; McWilliams A; Rifkin DE; Slinin Y; Taylor A; Townsend R; Wall B; Wright JT; Rahman M
    Hypertension; 2017 Jan; 69(1):42-50. PubMed ID: 27849563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intensive blood pressure lowering in different age categories: insights from the Systolic Blood Pressure Intervention Trial.
    Byrne C; Pareek M; Vaduganathan M; Biering-Sørensen T; Qamar A; Pandey A; Olesen TB; Olsen MH; Bhatt DL
    Eur Heart J Cardiovasc Pharmacother; 2020 Nov; 6(6):356-363. PubMed ID: 31529024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stroke risk in systolic and combined systolic and diastolic hypertension determined using ambulatory blood pressure. The Ohasama study.
    Inoue R; Ohkubo T; Kikuya M; Metoki H; Asayama K; Obara T; Hirose T; Hara A; Hoshi H; Hashimoto J; Totsune K; Satoh H; Kondo Y; Imai Y
    Am J Hypertens; 2007 Oct; 20(10):1125-31. PubMed ID: 17903698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood Pressure Variability Predicts Adverse Events and Cardiovascular Outcomes in Chronic Kidney Disease: A Post-Hoc Analysis of the SPRINT Trial.
    Mezue K; Goyal A; Pressman GS; Horrow JC; Rangaswami J
    Am J Hypertens; 2017 Dec; 31(1):48-52. PubMed ID: 28985328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.